Therapeutic agent

Sodium Oxybate

ModerateEvidence level
3Registered trials
1Conditions
0Study references

Evidence Summary

Evidence Level
Moderate
Mechanism
Enrollment: Actual, Sponsor Type: Other, Unknown / General
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 3 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

3 trial(s) registered

NCT IDTitlePhaseStatus
NCT01584934Sodium Oxybate in Patients With Chronic Fatigue Syndrome.Phase 4Withdrawn
NCT02055898SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)Phase 4Completed
NCT00498485Use of Xyrem to Improve Sleep in Chronic Fatigue SyndromePhase 4Terminated

Key Studies / References

  • See linked studies